ANALYSIS OF DRUG COST TOWARD CAPITATION COST FOR TOP DISEASES IN SPECIAL REGION OF YOGYAKARTA PUBLIC HEALTH CENTERS

  • Satibi Satibi Department of Pharmaceutics, Pharmacy Faculty, Universitas Gadjah Mada, Indonesia.
  • Risma Sakti Pambudi Department of Pharmaceutics, Pharmacy Faculty, Universitas Gadjah Mada, Indonesia.
  • Trisnadewi N Department of Pharmaceutics, Pharmacy Faculty, Universitas Gadjah Mada, Indonesia.
  • Wilonakaulika Wilonakaulika Department of Pharmaceutics, Pharmacy Faculty, Universitas Gadjah Mada, Indonesia.
  • Diahayupuspandari Diahayupuspandari Department of Health Policy Management, Faculty of Medical, Universitas Gadjah Mada, Indonesia.

Abstract

Objective: In this study wanted to analyze the differences between actual and standard of prescription cost. Researchers also conducted an analysis to see whether there was a difference between actual and standard of drug value in the amount of capitation fund.

Methods: This study was a retrospective observational analytic. Medical prescriptions (January 2015–June 2015) will be obtained at several Puskesmas in D.I Yogyakarta. Mann–Whitney test was performed to conduct whether there was a difference between actual and standard of prescription cost. Independent sample t-test was performed to conduct whether there was a difference between actual and standard of drug value in the amount of capitation fund.

Results: Based on the data, it showed that there was a significant difference (p<0.05) between actual and standard of prescription cost. There was also a significant difference between actual and standard of drug value in the amount of capitation fund at Puskesmas in Yogyakarta city and Bantul district. The difference of value caused by prescription cost value factor that there is duration component in calculation. Yet in Sleman district, there was no significant difference (p>0.05).

Conclusion: There was a significant difference between actual and standard of prescription cost. There was also a significant difference between actual and standard of drug value in the amount of capitation fund at Puskesmas in Yogyakarta city and Bantul district. Yet in Sleman district, there was no significant difference.

Keywords: Capitation system, BPJS, Cost analysis, Top five diseases, Puskesmas.

References

1. Satibi S, Puspandar DA, Cristanti PA, Sendi SL. Factors affecting patient satisfaction in JKN system: Study on patient characteristics, jkn services, and pharmacy services. Indone J Pharm 2015;26(4): 233-240.
2. BPJS. Regulation of the Social Security Administering Body of Health, No. 2 of 2015, Norms of Implementation of Capacity and Capacity- Based Payments commitment of Service Commitment to First Level Health Facilities. Jakarta: BPJS; 2015.
3. Ministry of Health. Regulation of the Minister of Health of the Republic of Indonesia Number 28 of 2014 on Guidelines for Implementation of National Health Insurance Program. Jakarta: Ministry of Health; 2014.
4. Satibi S, Dewi DA, Atika DA, Kaswindiarti N, Paspandari DA. Drug cost analysis on national insurance era in health support facilites. Asian J Pharm Clin Res 2017;10:119-21.
5. Sudarsono S. Identification of Drug Related Problem and Value Analysis of Prescription Cost and Percentage of Drug Components in Tariffs of Capitation Rates of Puskesmas in Pangkal Pinang City, Thesis, Universitas Gadjah Mada; 2016.
6. Nachiy RA, Parimalakrishnan S, Rao MR. Cost analysis of antihypertensive agents in rural population: A prospective study. Int J Pharm Pharm Sci 2016;8:225-30.
7. Ministry of Health. Regulation of the Minister of Health No. 5 of 2014 on Doctor Clinical Practice Guidance at Primary Health Care Facilities. Jakarta: Ministry of Health; 2014a.
8. World Health Organization. Definition and General Consideration: Defined Daily Dose. Geneva: World Health Organization; 2016. Available from: http://www.whocc.no/ddd/definition_and_general_ considera.
9. Forster DP, Frost CE. Use of regression analysis to explain the variation in prescribig rates and cost between family practitioner committees. Br J Gen Pract 1991;41:67-71.
10. Baker D, Klein R. Explaining output of primary health care: Population and Practice Factors. Br Med J 1991;303:225-9.
11. Mujasi PN, Junoy JP. What variables should be consideres in allocating primary health care pharmaceutical budgets to districts in Uganda. J Pharm Policy Pract 2015;8:3.
12. Prawitasari, Dwiprahasto I, dan Danu SS. The effect of drug availability on drug use patterns on therapy of five diseases at public health center at palangkaraya city public health cente. J Health Serv Manage 2002;5:83-92.
13. Morgan SG, Law M, Daw JR, Abraham L, Martin D. Estimated cost of universal public coverage of prescription drug in Canada. Can Med Assoc J 2015;187:491-7.
14. Barnett M, Frank J, Wehring H, Newland B, dan VanMouster S. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm 2009;15:18-31.
15. Nurcahyo H, Marchaban M, Sumarni S. Human quality of service in the age of national healthcare guarantee against patient satisfaction. J Manage Pharm Serv 2015;5:104-8.
Statistics
164 Views | 258 Downloads
Citatons
How to Cite
Satibi, S., R. S. Pambudi, T. N, W. Wilonakaulika, and D. Diahayupuspandari. “ANALYSIS OF DRUG COST TOWARD CAPITATION COST FOR TOP DISEASES IN SPECIAL REGION OF YOGYAKARTA PUBLIC HEALTH CENTERS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 8, Aug. 2018, pp. 189-93, doi:10.22159/ajpcr.2018.v11i8.25608.
Section
Original Article(s)